✦ LIBER ✦

Complex I, Iron, and ferritin in Parkinson's disease substantia nigra

✍ Scribed by V. M. Mann; J. M. Cooper; S. E. Daniel; K. Srai; P. Jenner; C. D. Marsden; Prof. A. H. V. Schapira

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 573 KB
Volume: 36
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410360612

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine transporter messenger RNA in Pa

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

✍ Dr. George R. Uhl; Donna Walther; Deborah Mash; Baptiste Faucheux; France Javoy- 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

No correlation of substantia nigra echog

No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease

✍ Elmar Lobsien; Simon Schreiner; Michail Plotkin; Andreas Kupsch; Stephan J. Schr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 758 KB

## Abstract ## Background: Substantia nigra hyperechogenicity assessed by transcranial sonography is a typical finding in up to 90% of patients with idiopathic Parkinson's disease, although its value as a surrogate marker for disease progression in Parkinson's disease is controversial. ^123^I‐FP‐C

High resolution magnetic susceptibility

High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease

✍ Ashley K. Lotfipour; Samuel Wharton; Stefan T. Schwarz; V. Gontu; Andreas Schäfe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract ## Purpose: To determine if tissue magnetic susceptibility is a more direct marker of tissue iron content than other MR markers of iron. This study presents the first quantitative, in vivo measurements of the susceptibility of the substantia nigra in patients with Parkinson's disease.

Substantia nigra hyperechogenicity as a

Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease

✍ Katherine J. Schweitzer; Rüdiger Hilker; Uwe Walter; Lothar Burghaus; Daniela Be 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound mar

Transcranial imaging of substantia nigra

Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease

✍ Yu-Wen Huang; Jiann-Shing Jeng; Chung-Fen Tsai; Li-Ling Chen; Ruey-Meei Wu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract Transcranial Doppler imaging (TCDI) has been used as a noninvasive diagnostic tool to differentiate Parkinson's disease (PD) from atypical parkinsonism by detecting hyperechogenicity in the substantia nigra (SN). To our knowledge, no TCDI data are available for Asian populations, and TC

Combined R2* and Diffusion Tensor Imagin

Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease

✍ Guangwei Du; Mechelle M. Lewis; Martin Styner; Michele L. Shaffer; Suman Sen; Qi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 1 views

Recent magnetic resonance imaging studies suggest an increased transverse relaxation rate and reduced diffusion tensor imaging fractional anisotropy values in the substantia nigra in Parkinson's disease. The transverse relaxation rate and fractional anisotropy changes may reflect different aspects o